Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
26 févr. 2020 07h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31, 2019....
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
11 févr. 2020 17h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on...
Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
21 nov. 2019 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The...
Harvard Bioscience Announces Third Quarter Financial Results
05 nov. 2019 16h00 HE
|
Harvard Bioscience, Inc.
Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 millionQ3 Operating Loss (GAAP) of $(1.4) million; Adjusted Operating...
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 nov. 2019 08h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular &...
Harvard Bioscience Announces Executive Appointment
31 oct. 2019 17h10 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular...
Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET
22 oct. 2019 18h31 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on...
Harvard Bioscience Announces Executive Appointment
21 oct. 2019 08h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems...
Harvard Bioscience Announces Strategic Action Plan and Financial Targets
09 sept. 2019 08h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key...
Harvard Bioscience Elects Alan Edrick to Board of Directors
04 sept. 2019 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of...